These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8476894)

  • 1. Vascular lesions in biopsy specimens devoid of cellular infiltrates: qualitative and quantitative immunocytochemical studies of human cardiac allografts.
    Faulk WP; Labarrere CA; Pitts D; Halbrook H
    J Heart Lung Transplant; 1993; 12(2):219-29. PubMed ID: 8476894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory-clinical correlates of time-associated lesions in the vascular immunopathology of human cardiac allografts.
    Faulk WP; Labarrere CA; Pitts D; Halbrook H
    J Heart Lung Transplant; 1993; 12(2):S125-34. PubMed ID: 8476882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular rejection in heart transplantation: clinical correlation, treatment options, and future considerations.
    Olsen SL; Wagoner LE; Hammond EH; Taylor DO; Yowell RL; Ensley RD; Bristow MR; O'Connell JB; Renlund DG
    J Heart Lung Transplant; 1993; 12(2):S135-42. PubMed ID: 8476883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte growth from cardiac allograft biopsy specimens with no or minimal cellular infiltrates: association with subsequent rejection episode.
    Weber T; Kaufman C; Zeevi A; Zerbe TR; Hardesty RJ; Kormos RH; Griffith BP; Duquesnoy RJ
    J Heart Transplant; 1989; 8(3):233-40. PubMed ID: 2661773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression.
    McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW
    J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular immunopathology and atheroma development in human allografted organs.
    Faulk WP; Labarrere CA
    Arch Pathol Lab Med; 1992 Dec; 116(12):1337-44. PubMed ID: 1456881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
    Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nature and significance of epicardial lymphoid infiltrates in cardiac allografts.
    Luthringer DJ; Yamashita JT; Czer LS; Trento A; Fishbein MC
    J Heart Lung Transplant; 1995; 14(3):537-43. PubMed ID: 7654737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of vascular endothelial growth factor in human cardiac allografts: association with rejection.
    Reinders ME; Fang JC; Wong W; Ganz P; Briscoe DM
    Transplantation; 2003 Jul; 76(1):224-30. PubMed ID: 12865814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
    Vassalli G; Kaski JC; Tousoulis D; Kiowski W; Turina M; Follath F; Gallino A
    J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometric and immunocytochemical analysis of coronary arterioles in human transplanted hearts.
    Armstrong AT; Strauch AR; Kardan A; Starling RC
    J Heart Lung Transplant; 1996 Aug; 15(8):818-26. PubMed ID: 8878764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular effects of cyclosporin A and acute rejection in canine heart transplantation.
    Bouchard D; Despatis MA; Buluran J; Cartier R
    Ann Thorac Surg; 1997 Nov; 64(5):1325-30. PubMed ID: 9386698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cytokine levels in heart allograft recipients: correlation with findings on endomyocardial biopsy.
    Jordan SC; Czer L; Toyoda M; Galfayan K; Doan D; Fishbein M; Blanche C; Trento A
    J Heart Lung Transplant; 1993; 12(2):333-7. PubMed ID: 8476907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin M antibodies in transplanted human hearts.
    Labarrere CA; Pitts D; Halbrook H; Faulk WP
    J Heart Lung Transplant; 1993; 12(3):394-402. PubMed ID: 8329409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased myocardial performance index correlates with biopsy-proven rejection in pediatric heart transplant recipients.
    Leonard GT; Fricker FJ; Pruett D; Harker K; Williams B; Schowengerdt KO
    J Heart Lung Transplant; 2006 Jan; 25(1):61-6. PubMed ID: 16399532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of Quilty lesion in cardiac allografts: relationship to reduced endocardial cyclosporine A.
    Freimark D; Czer LS; Aleksic I; Ruan XM; Admon D; Blanche C; Trento A; Fishbein MC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1197-203. PubMed ID: 8719467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator, plasminogen activator inhibitor-1, and fibrin as indexes of clinical course in cardiac allograft recipients. An immunocytochemical study.
    Labarrere CA; Pitts D; Halbrook H; Faulk WP
    Circulation; 1994 Apr; 89(4):1599-608. PubMed ID: 8149527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.